China Universal Asset Management Co., Ltd. Phathom Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,022 shares of PHAT stock, worth $169,666. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,022
Previous 13,715
2.24%
Holding current value
$169,666
Previous $85,000
57.65%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding PHAT
# of Institutions
138Shares Held
60.5MCall Options Held
1.35MPut Options Held
1.19M-
Frazier Life Sciences Management, L.P. Menlo Park, CA12.5MShares$151 Million6.31% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$90.3 Million20.28% of portfolio
-
Invesco Ltd. Atlanta, GA4.14MShares$50.1 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$42.3 Million41.56% of portfolio
-
Black Rock Inc. New York, NY2.93MShares$35.4 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $474M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...